Product Information
DIGOXIN 0.25 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1614 per EA under NDC 57664044118. Its NADAC has been published 596 times since Nov 28, 2013.
FDA first approved this application on Jan 31, 2003.
Strength
250 ug/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664044118
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIGOXINApproval Type
Generic (ANDA)
FDA Application
ANDA076363FDA Approved
1/31/2003
On Market Since
2/17/2015
Pharmacological Classes
Price Statistics
The NADAC for DIGOXIN 0.25 MG TABLET has been published 596 times since Nov 28, 2013, and over the history we have for it it has risen 39.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1614 per EA |
|---|---|
| All-time high | $1.1823 (Mar 12, 2014) |
| All-time low | $0.1154 (Nov 28, 2013) |
| 52-week high | $0.1614 |
| 52-week low | $0.1347 |
| Median price | $0.3155 |
| Average price | $0.3831 |
| Largest weekly change | +779.3% (Dec 18, 2013) |
| Weeks tracked | 596 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
+0.9%
6M
+19.8%
1Y
+10.9%
3Y
-15.0%
5Y
-47.1%
All
+39.9%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Digoxin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cardiac Glycoside class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIGOXIN 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIGOXIN 0.25 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1614 per EA (NDC 57664044118), effective Aug 19, 2026.
How has the price of DIGOXIN 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIGOXIN 0.25 MG TABLET has risen 39.9%. It has been tracked across 596 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIGOXIN 0.25 MG TABLET?
Since Nov 28, 2013, the NADAC for DIGOXIN 0.25 MG TABLET has ranged from a low of $0.1154 (Nov 28, 2013) to a high of $1.1823 (Mar 12, 2014), with a median of $0.3155 per EA.
Are there cheaper alternatives to DIGOXIN 0.25 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIGOXIN 250 MCG TABLET, is $0.1484 per EA — about 8% below DIGOXIN 0.25 MG TABLET.
Who manufactures DIGOXIN 0.25 MG TABLET?
DIGOXIN 0.25 MG TABLET (NDC 57664044118) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.